---
schema_version: "secwatch.filing_event.v1"
accession: "0001174947-24-000936"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:40:59.395079+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CONMED Q2 adj EPS $0.98 beats; cuts FY revenue & EPS guidance on supply chain delays

## Summary
- Revenue $332.1M (+4.5% reported, +5.2% constant currency); GAAP EPS $0.96 vs $0.43; adj EPS $0.98 vs $0.83 (+18.1%).
- Full-year revenue guidance lowered to $1.305-1.315B from $1.330-1.355B; adj EPS guidance cut to $3.95-4.02 from $4.25-4.35.
- CEO cites unresolved supply chain challenges delaying commercial reacceleration, impacting second half outlook.
- Orthopedic Surgery sales -0.9% YoY; General Surgery +8.9%; Domestic +6.1%, International +2.6% reported.
- Adjusted EBITDA $64.6M (19.4% margin) vs $57.6M (18.1%) in Q2 2023.

## SEC filing metadata
- accession: 0001174947-24-000936
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000117494724000936/0001174947-24-000936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000117494724000936/form8k-32663_cnmd.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001174947-24-000936
- JSON: https://secwatch.observer/filing/0001174947-24-000936.json
- Plain text: https://secwatch.observer/filing/0001174947-24-000936.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.